| 产品描述: | PP121 is a multi-targeted kinase inhibitor with IC50s of 10, 60, 12, 14, 2 nM for mTOR, DNK-PK, VEGFR2, Src, PDGFR, respectively. |
| 靶点: |
VEGFR2:12 nM (IC50);PDGFR:2 nM (IC50);mTOR:10 nM (IC50);DNK-PK:60 nM (IC50);Src:14 nM (IC50);Apoptosis;VEGFR;Bcr-Abl;PDGFR;Src;mTOR;Hck |
| 体内研究: |
Oral administration of PP121 remarkably inhibits Eca-109 xenograft growth. Mice body weights are not significantly affected by PP121 or the vehicle treatment. PP121 oral administration dramatically inhibits activations of Akt-mTOR and NFkB in xenograft tumors. p-Akt Ser 473 and p-IKKa/b are both inhibited by PP121 administration |
| 参考文献: |
1. Apsel B, et al. Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases. Nat Chem Biol, 2008, 4(11), 691-699. 2. Peng Y, et al. The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121. Biochem Biophys Res Commun. 2015 Sep 11;465(1):137-44. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
2-8℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.131 ml |
15.656 ml |
31.313 ml |
| 5 mM |
0.626 ml |
3.131 ml |
6.263 ml |
| 10 mM |
0.313 ml |
1.566 ml |
3.131 ml |
| 50 mM |
0.063 ml |
0.313 ml |
0.626 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |